Showing results (41-50 of 844) with videos related to
Sort By:
Pageof 85
Radiation Research|May 1, 1990
Inhibition of hematopoietic recovery from radiation-induced myelosuppression by natural killer cellsK Pantel, J Boertman, A NakeffRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 22, 1998
Diagnosis and therapeutic relevance of micrometastasesE Holz, K Pantel, G RiethmüllerBritish Journal of Haematology|June 1, 1990
Stem cell recovery from cyclophosphamide-induced myelosuppression requires the presence of CD4+ cellsK Pantel, Z Djuric, A NakeffJournal of the National Cancer Institute|July 7, 1999
Detection and clinical importance of micrometastatic diseaseK Pantel, R J Cote, O FodstadThe New England Journal of Medicine|February 24, 2000
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancerS Braun, K Pantel, P Müller, et al.Der Urologe. Ausg. A|March 28, 2014
[Detection of circulating tumor cells from peripheral blood in prostate cancer]M Thalgott, M M Heck, K PantelEuropean Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 15, 2013
Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-upN Möckelmann, S Laban, K Pantel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cellsA Zippelius, R Lutterbüse, G Riethmüller, et al.Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1996
[Limits of surgery in patients with apparently localized bronchial carcinoma (pT1-3, pN0, M0)]B Passlick, O Thetter, K Pantel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2019
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?P Hofman, S Heeke, C Alix-Panabières, et al.Pageof 85